Viewing Study NCT00862706


Ignite Creation Date: 2025-12-26 @ 4:04 PM
Ignite Modification Date: 2026-02-24 @ 5:40 AM
Study NCT ID: NCT00862706
Status: WITHDRAWN
Last Update Posted: 2016-09-23
First Post: 2009-03-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy of Telbivudine in Blacks/African Americans and Hispanics/Latinos With Compensated Chronic Hepatitis B During 52 Weeks
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module